本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ensysce Biosciences Inc.

0.3186
-0.0045-1.39%
盤後0.3020-0.0166-5.21%19:49 EDT
成交量:69.76萬
成交額:21.31萬
市值:468.17萬
市盈率:-0.10
高:0.3186
開:0.3134
低:0.2950
收:0.3231
52周最高:2.75
52周最低:0.2300
股本:1,469.45萬
流通股本:926.75萬
量比:0.62
換手率:7.53%
股息:- -
股息率:- -
每股收益(TTM):-3.3422
每股收益(LYR):-11.4482
淨資產收益率:-1149.11%
總資產收益率:-218.22%
市淨率:-13.77
市盈率(LYR):-0.03

資料載入中...

公司資料

公司名字:
Ensysce Biosciences Inc.
交易所:
NASDAQ
成立時間:
2003
員工人數:
9
公司地址:
7946 Ivanhoe Avenue,Suite 201,La Jolla,California,United States
郵編:
92037
電話:
傳真:
- -
簡介:
Ensysce Biosciences, Inc.於2003年4月在特拉華州註冊成立。該公司是一家臨床階段的製藥公司,致力於開發創新方案以緩解重度疼痛,同時降低阿片類藥物誤用、濫用和過量服用的風險。該公司目前正在研發旨在提高處方藥安全性的候選產品。

董事

名稱
職位
Bob Gower
Chairman and Independent Director
Lynn Kirkpatrick
President,Chief Executive Officer and Director
Adam S. Levin
Independent Director
Curtis Rosebraugh
Independent Director
Lee Rauch
Independent Director
Steve Martin
Independent Director
William Chang
Independent Director

股東

名稱
職位
Lynn Kirkpatrick
President,Chief Executive Officer and Director
Jeffrey Millard
Chief Operating Officer
David Humphrey
Chief Financial Officer,Secretary and Treasurer
Geoffrey Birkett
Chief Commercial Officer
Linda Pestano
Chief Development Officer
William K. Schmidt
Chief Medical Officer